Mr. Paxton and the other attorneys general are using a variety of legal maneuvers, such as issuing subpoenas to obtain documents and testimony, to assess whether opioid manufacturers have partaken in practices that have contributed to the nationwide opioid addiction epidemic, according to the report.
“This is a public safety and public health issue. Opioid painkiller abuse and related overdoses are devastating families here in Texas and throughout the country,” Mr. Paxton said in a statement, according to the report. “The multistate investigation will help us determine the appropriate course of action we can take as attorneys general to address the opioid epidemic.”
Mr. Paxton’s spokesperson declined to offer more details on the investigation, such as how many other attorneys general are involved or if the group is targeting specific drugmakers.
Representatives from the Pharmaceutical Research and Manufacturers of America, the nation’s largest pharmaceutical trade group, did not immediately respond to The Texas Tribune‘s request for a comment.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
